Rangoon Creeper

Quisqualis indica contains quisqualic acid (an AMPA receptor agonist), tormentic acid, rutin, ellagic acid, and a broad spectrum of flavonoids, alkaloids, and terpenoids that collectively exert anthelmintic, antioxidant, antibacterial, and immunomodulatory effects. In vitro antibacterial testing of the flower petroleum ether extract demonstrated inhibition zones up to 26 mm against Staphylococcus aureus and Bacillus subtilis at 50 mg/mL, with MIC values of 27–40 µg/mL, while ethyl acetate fractions yielded DPPH scavenging SC₅₀ values of 24.38–72.10 µg/mL across studied batches.

Origin & History

Quisqualis indica is native to tropical and subtropical regions of South and Southeast Asia, including the Philippines, India, Myanmar, and southern China, where it grows as a vigorous climbing vine in lowland forests, forest margins, and disturbed habitats at elevations below 1,000 meters. It thrives in warm, humid climates with well-drained soils and full sun to partial shade, commonly cultivated as an ornamental plant along fences and trellises due to its fragrant, multi-colored flowers. Traditional cultivation spans centuries across Filipino, Chinese, and Indian herbal medicine communities, where specific plant parts — seeds, fruits, leaves, roots, and flowers — are harvested seasonally for medicinal preparations.

Historical & Cultural Context

Quisqualis indica has a long history of use in traditional medicine systems across Southeast Asia and East Asia, known as 'Niyog-niyogan' in Filipino ethnobotany and as 'Shi jun zi' (使君子) in Traditional Chinese Medicine, where it has been prescribed for roundworm and pinworm infections for over a thousand years and is referenced in classical TCM texts including the Compendium of Materia Medica (Bencao Gangmu) by Li Shizhen. In Philippine traditional medicine, roasted seeds are among the officially recognized herbal remedies endorsed by the Department of Health for helminthiasis, reflecting deep cultural integration of the plant into primary healthcare in resource-limited settings. Indian Ayurvedic and Unani practitioners have also employed the plant for digestive disorders, fevers, and skin conditions, preparing decoctions and poultices from the leaves and roots. The plant's ornamental value — with flowers transitioning from white to pink to red over several days — has also made it a culturally significant garden plant across tropical Asia, blending aesthetic and medicinal traditions.

Health Benefits

- **Anthelmintic (Anti-parasitic) Activity**: The seeds and fruits of Quisqualis indica have been traditionally used in Filipino herbal medicine for helminthiasis; bioactive constituents including quisqualic acid and tormentic acid are implicated in disrupting neuromuscular function in intestinal worms, and the plant remains listed in the Philippine National Formulary for this use.
- **Antibacterial Properties**: Flower extracts, particularly petroleum ether and methanol fractions, inhibit the growth of Gram-positive bacteria such as Staphylococcus aureus and Bacillus subtilis, with inhibition zones reaching 26 mm at 50 mg/mL, a mechanism attributed to alkaloids, steroids, and phenolic compounds disrupting microbial membrane integrity.
- **Antioxidant Activity**: The ethyl acetate fraction of Quisqualis indica flowers exhibits DPPH free radical scavenging with SC₅₀ values of 24.38–72.10 µg/mL, driven primarily by polyphenols including rutin, luteolin, ellagic acid, gallic acid, and kaempferol, though this activity is weaker than ascorbic acid (SC₅₀ 7.45 µg/mL).
- **Immunomodulatory Effects**: Flavonoids (rutin, luteolin, genistein), tannins, saponins, and alkaloids in the plant have demonstrated immunomodulatory potential in preliminary studies, proposed to enhance pathogen defense responses while simultaneously attenuating oxidative damage through complementary anti-inflammatory mechanisms.
- **Anti-cancer Potential (Preclinical)**: Fruit extracts have shown inhibition of liver cancer cell proliferation in preclinical models, with the phytochemical complexity of Quisqualis fruits — encompassing over 100 identified constituents including 29 fatty acids, 26 organic acids, and 11 amino acids — suggesting multi-target cytotoxic activity requiring further mechanistic elucidation.
- **Benign Prostatic Hyperplasia (BPH) Improvement**: Preliminary animal model studies indicate that Quisqualis indica fruit preparations may improve markers associated with benign prostatic hyperplasia, though the specific compounds responsible and the precise mechanisms remain incompletely characterized.
- **Anti-insecticidal and Anti-parasitic (Giardia)**: Extracts have demonstrated insecticidal activity against mosquito larvae and inhibitory effects against Giardia in experimental settings, broadening the traditional anthelmintic applications to protozoal and vector-borne disease contexts.

How It Works

Quisqualic acid (C₅H₇N₃O₅), a structural analog of glutamate, acts as a potent agonist at AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors and, at higher concentrations, at metabotropic glutamate receptors, which may underlie the neuromuscular disruption in helminths leading to paralysis and expulsion. Phenolic compounds — including gallic acid, ellagic acid, rutin, luteolin, and quercetin-3-(2-galloyl glucoside) — scavenge reactive oxygen species via electron donation and hydrogen atom transfer, chelate redox-active metals, and modulate the Nrf2/ARE antioxidant response pathway to upregulate endogenous antioxidant enzymes. Alkaloids, steroids, and flavonoids present in flower fractions are proposed to disrupt bacterial membrane permeability and integrity, with MIC values of 27–40 µg/mL against tested Gram-positive strains suggesting potent membrane-targeting activity. Tannins and saponins contribute to immunomodulation by interacting with toll-like receptors and complement pathways, modulating cytokine expression patterns to support both innate and adaptive immune homeostasis, though these pathway interactions have not been confirmed in receptor-level binding studies for this species specifically.

Scientific Research

The body of evidence for Quisqualis indica consists entirely of in vitro and animal model studies, with no published human clinical trials identified in the peer-reviewed literature as of the latest available data. Phytochemical characterization studies, including HPLC and GC-MS analyses, have confirmed the presence of over 100 constituents in the fruit fraction alone, and batch consistency studies using simultaneous HPLC quantification of trigonelline, adenosine, ellagic acid, and 3,3'-di-O-methylellagic acid demonstrated inter-batch similarity indices of 0.870–0.999, suggesting reasonable quality control potential for standardized preparations. Antibacterial efficacy has been evaluated in agar disc diffusion and broth microdilution assays, with quantified inhibition zones and MIC values providing preliminary benchmarks, but these are not replicated in infection models or clinical settings. The preclinical quality and quantity of evidence is insufficient to establish clinical efficacy, effective dosing, or safety profiles in humans, placing this ingredient firmly in the category of traditional/preliminary research with significant knowledge gaps.

Clinical Summary

No human randomized controlled trials, cohort studies, or systematic reviews have been conducted on Quisqualis indica for any indication. Available pharmacological data derive from in vitro cell-based assays, insecticidal screening studies, and limited animal model experiments examining anticancer, BPH-related, and antimicrobial endpoints without quantified effect sizes applicable to human therapeutic contexts. The plant's anthelmintic use in Filipino traditional medicine, including its inclusion in Philippine herbal medicine guidelines, is grounded in ethnopharmacological evidence rather than controlled clinical outcomes. Confidence in clinical efficacy for any indication remains very low; definitive conclusions cannot be drawn pending properly designed, placebo-controlled human trials.

Nutritional Profile

Quisqualis indica fruit (QF) contains a complex array of phytochemicals rather than a conventional macronutrient profile relevant to dietary supplementation. The fruit fraction has been analytically characterized as containing 29 fatty acid species, 26 organic acids, 11 amino acids (including L-proline and L-asparagine), and flavonoids such as rutin (C₂₇H₃₀O₁₆), luteolin, kaempferol, genistein, myricitrin, and quercetin-3-(2-galloyl glucoside). Alkaloids include quisqualic acid and trigonelline; terpenoids include α-farnesene and the sesquiterpene alcohol viridiflorol (C₁₅H₂₆O); polyphenols include gallic acid (C₇H₆O₅), ellagic acid, and 3,3'-di-O-methylellagic acid; saponins and tannins are also present across plant parts. Absolute quantitative concentrations for most constituents are not reported in available literature, and bioavailability data — including absorption, distribution, metabolism, and excretion parameters — have not been established for any constituent in human pharmacokinetic studies.

Preparation & Dosage

- **Traditional Decoction (Seeds/Fruits)**: In Filipino folk medicine, roasted or fresh seeds (approximately 3–5 seeds per dose for children; 7–10 for adults) are consumed orally for intestinal worms, typically on an empty stomach; this is not a standardized pharmaceutical dose.
- **Crude Methanol Extract**: Laboratory maceration of flowers yields approximately 17.41% w/w methanol extract; used in research at concentrations of 50 mg/mL for antibacterial screening, with no human dose equivalent established.
- **Ethyl Acetate Fraction**: Yields approximately 3.19% w/w from flowers; demonstrates highest antioxidant activity (DPPH SC₅₀ 24.38–72.10 µg/mL); no supplemental dose defined for human use.
- **N-Hexane Extract**: Yields approximately 1.45% w/w from flowers; used in preclinical insecticidal and antimicrobial assays at various concentrations.
- **Aqueous Preparation (Tea/Infusion)**: Leaves and flowers prepared as aqueous infusion in traditional Southeast Asian systems for digestive and immune support; volume and concentration are not standardized.
- **Standardization**: No commercially standardized extracts (e.g., percent tormentic acid or quisqualic acid) have been identified in the available literature; no pharmacopoeial monograph dose has been established for international markets.

Synergy & Pairings

In traditional Filipino and Chinese preparations, Quisqualis indica seeds are sometimes combined with other anthelmintic herbs such as betel nut (Areca catechu) or papaya seeds (Carica papaya), where complementary disruption of helminth neuromuscular junctions and tegumental integrity may produce additive or synergistic antiparasitic effects. The flavonoid-rich fraction of Quisqualis indica — particularly rutin and quercetin derivatives — may synergize with vitamin C (ascorbic acid) to regenerate oxidized flavonoid radicals back to their active antioxidant form, a well-documented flavonoid-ascorbate redox cycling mechanism that could enhance overall antioxidant capacity. Pairing with zinc-containing preparations has been proposed in traditional contexts for immune modulation, as zinc and flavonoids both modulate NF-κB signaling and toll-like receptor pathways, though no experimental data for this specific combination with Quisqualis indica have been published.

Safety & Interactions

Formal toxicological profiling of Quisqualis indica in humans is absent from the published literature, and neither specific adverse effect frequencies, maximum tolerated doses, nor no-observed-adverse-effect levels (NOAELs) have been established through controlled studies. Quisqualic acid's potent AMPA receptor agonist activity raises a theoretical neuroexcitatory risk at elevated doses — analogous to excitotoxic mechanisms — which could manifest as seizures or neurological symptoms, particularly with excessive seed consumption; historical reports of nausea, hiccups, and dizziness following large seed doses in children have been noted in ethnopharmacological literature. No formal drug interaction studies exist, but the presence of flavonoids (e.g., kaempferol, genistein) that modulate CYP450 enzymes (particularly CYP1A2 and CYP3A4) suggests a theoretical potential to alter the metabolism of co-administered pharmaceuticals including anticoagulants, anticonvulsants, and immunosuppressants. Pregnant and lactating women should avoid medicinal doses given the complete absence of reproductive safety data; the plant is not recommended for therapeutic self-administration outside of its traditional supervised context pending rigorous clinical safety evaluation.